On March 10, 2026, bioAffinity Technologies, Inc. announced the start of a large-scale clinical study for CyPath® Lung, a noninvasive test for early-stage lung cancer detection.
AI Assistant
BIOAFFINITY TECHNOLOGIES INC
2026
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.